Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
Nele Claes, Judith Fraussen, Piet Stinissen, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 549
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
Joana Machado‐Santos, Etsuji Saji, Anna R. Tröscher, et al.
Brain (2018) Vol. 141, Iss. 7, pp. 2066-2082
Open Access | Times Cited: 443
Targeting B Cells and Plasma Cells in Autoimmune Diseases
Katharina Hofmann, Ann‐Katrin Clauder, Rudolf A. Manz
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 235
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Tobias Moser, Katja Akgün, Undine Proschmann, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 10, pp. 102647-102647
Closed Access | Times Cited: 212
IgD−CD27− double negative (DN) B cells: Origins and functions in health and disease
Lien Beckers, Veerle Somers, Judith Fraussen
Immunology Letters (2023) Vol. 255, pp. 67-76
Closed Access | Times Cited: 45
Update on Disease-Modifying Therapies for Multiple Sclerosis
Diana Vargas, William R. Tyor
Journal of Investigative Medicine (2017) Vol. 65, Iss. 5, pp. 883-891
Closed Access | Times Cited: 126
New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Chih‐Chung Lin, Brian T. Edelson
The Journal of Immunology (2017) Vol. 198, Iss. 12, pp. 4553-4560
Open Access | Times Cited: 125
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Luc Van Kaer, J. Luke Postoak, Chuan Wang, et al.
Cellular and Molecular Immunology (2019) Vol. 16, Iss. 6, pp. 531-539
Open Access | Times Cited: 117
The physiology of foamy phagocytes in multiple sclerosis
Elien Grajchen, Jerome J. A. Hendriks, Jeroen F. J. Bogie
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 110
Hello from the Other Side: How Autoantibodies Circumvent the Blood–Brain Barrier in Autoimmune Encephalitis
Maryann P. Platt, Dritan Agalliu, Tyler Cutforth
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 93
Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
Gwendoline Montes Diaz, Raymond Hupperts, Judith Fraussen, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 12, pp. 1240-1250
Closed Access | Times Cited: 93
The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders
Aradhana Prajapati, Sidharth Mehan, Zuber Khan
Biogerontology (2023) Vol. 24, Iss. 4, pp. 493-531
Closed Access | Times Cited: 23
B-Cell Therapies in Multiple Sclerosis
Joseph J. Sabatino, Scott S. Zamvil, Stephen L. Hauser
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 2, pp. a032037-a032037
Open Access | Times Cited: 73
Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients
Gwendoline Montes Diaz, Judith Fraussen, B. Van Wijmeersch, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation
Fredrick G. Karnell, Dan Lin, Samantha Motley, et al.
Clinical & Experimental Immunology (2017) Vol. 189, Iss. 3, pp. 268-278
Open Access | Times Cited: 69
Interrelation of Diet, Gut Microbiome, and Autoantibody Production
Ιωάννα Πέττα, Judith Fraussen, Veerle Somers, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 63
Circulating immune cells in multiple sclerosis
A P Jones, Allan G. Kermode, Robyn Lucas, et al.
Clinical & Experimental Immunology (2016) Vol. 187, Iss. 2, pp. 193-203
Open Access | Times Cited: 59
The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)
C. Bolton, Paul A. Smith
Ageing Research Reviews (2017) Vol. 41, pp. 64-81
Closed Access | Times Cited: 49
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
Georgios K. Vasileiadis, Efthimios Dardiotis, Αthanasios Mavropoulos, et al.
Autoimmunity Highlights (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Sustained immunotolerance in multiple sclerosis after stem cell transplant
Malini Visweswaran, Kevin Hendrawan, Jennifer Massey, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 2, pp. 206-220
Open Access | Times Cited: 22
Progress in nanoparticle-based regulation of immune cells
Ya-Nan Fan, Gui Zhao, Yue Zhang, et al.
Medical Review (2023) Vol. 3, Iss. 2, pp. 152-179
Open Access | Times Cited: 12
Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis
Arezoo Hosseini, Ali Masjedi, Behzad Baradaran, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 9943-9955
Closed Access | Times Cited: 37
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study
Irene Moreno‐Torres, Coral González‐García, M. Marconi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 36
Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell intervention
Min Li, Ya-Nan Fan, Zhiyao Chen, et al.
Nano Research (2018) Vol. 11, Iss. 12, pp. 6270-6282
Closed Access | Times Cited: 35
Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis
Brittany L. Hartwell, Chad J. Pickens, Martin A. Leon, et al.
Journal of Autoimmunity (2018) Vol. 93, pp. 76-88
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top